Structural basis for inhibition of the fat mass and obesity associated protein (FTO).

The fat mass and obesity associated protein (FTO) is a potential target for anti-obesity medicines. FTO is a 2-oxoglutarate (2OG)-dependent N-methyl nucleic acid demethylase that acts on substrates including 3-methylthymidine, 3-methyluracil, and 6-methyladenine. To identify FTO inhibitors, we screened a set of 2OG analogues and related compounds using differential scanning fluorometry- and liquid chromatography-based assays. The results revealed sets of both cyclic and acyclic 2OG analogues that are FTO inhibitors. Identified inhibitors include small molecules that have been used in clinical studies for the inhibition of other 2OG oxygenases. Crystallographic analyses reveal inhibition by 2OG cosubstrate or primary substrate competitors as well as compounds that bind across both cosubstrate and primary substrate binding sites. The results will aid the development of more potent and selective FTO inhibitors.

[1]  Michael A McDonough,et al.  Dynamic combinatorial chemistry employing boronic acids/boronate esters leads to potent oxygenase inhibitors. , 2012, Angewandte Chemie.

[2]  Ye Fu,et al.  Nucleic acid modifications with epigenetic significance. , 2012, Current opinion in chemical biology.

[3]  G. Bormans,et al.  The Effect of a Methyl or 2-fluoroethyl Substituent at the N-3 Position of Thymidine, 3′-fluoro-3′-deoxythymi-dine and 1-β-D-arabinosylthymine on Their Antiviral and Cytostatic Activity in Cell Culture , 2006, Antiviral chemistry & chemotherapy.

[4]  Robert P. Hausinger,et al.  Fe(II)/α-Ketoglutarate-Dependent Hydroxylases and Related Enzymes , 2004 .

[5]  F. Niesen,et al.  The use of differential scanning fluorimetry to detect ligand interactions that promote protein stability , 2007, Nature Protocols.

[6]  Qiang Wang,et al.  Crystal structure of the FTO protein reveals basis for its substrate specificity , 2010, Nature.

[7]  Chris P. Ponting,et al.  The Obesity-Associated FTO Gene Encodes a 2-Oxoglutarate-Dependent Nucleic Acid Demethylase , 2007, Science.

[8]  Michael A McDonough,et al.  Dynamic combinatorial mass spectrometry leads to inhibitors of a 2-oxoglutarate-dependent nucleic acid demethylase. , 2012, Journal of medicinal chemistry.

[9]  Chengqi Yi,et al.  N6-Methyladenosine in Nuclear RNA is a Major Substrate of the Obesity-Associated FTO , 2011, Nature chemical biology.

[10]  Chengqi Yi,et al.  Oxidative demethylation of 3‐methylthymine and 3‐methyluracil in single‐stranded DNA and RNA by mouse and human FTO , 2008, FEBS letters.

[11]  P. Emsley,et al.  Features and development of Coot , 2010, Acta crystallographica. Section D, Biological crystallography.

[12]  Roger D. Cox,et al.  A Mouse Model for the Metabolic Effects of the Human Fat Mass and Obesity Associated FTO Gene , 2009, PLoS genetics.

[13]  F. Sobott,et al.  Application of a proteolysis/mass spectrometry method for investigating the effects of inhibitors on hydroxylase structure. , 2009, Journal of medicinal chemistry.

[14]  Randy J. Read,et al.  Phaser crystallographic software , 2007, Journal of applied crystallography.

[15]  A. Jadhav,et al.  Quantitative High-Throughput Screening Identifies 8-Hydroxyquinolines as Cell-Active Histone Demethylase Inhibitors , 2010, PloS one.

[16]  Jiannis Ragoussis,et al.  Concordant Regulation of Gene Expression by Hypoxia and 2-Oxoglutarate-dependent Dioxygenase Inhibition , 2006, Journal of Biological Chemistry.

[17]  Eyal Gottlieb,et al.  Inborn and acquired metabolic defects in cancer , 2011, Journal of Molecular Medicine.

[18]  P. Ratcliffe,et al.  2-oxoglutarate analogue inhibitors of HIF prolyl hydroxylase. , 2003, Bioorganic & medicinal chemistry letters.

[19]  C. Schofield,et al.  Inhibition of 2-oxoglutarate dependent oxygenases. , 2011, Chemical Society reviews.

[20]  Randy J. Read,et al.  Acta Crystallographica Section D Biological , 2003 .

[21]  M. Jarvelin,et al.  A Common Variant in the FTO Gene Is Associated with Body Mass Index and Predisposes to Childhood and Adult Obesity , 2007, Science.

[22]  Eleanor A. L. Bagg,et al.  The potential of 2-oxoglutarate oxygenases acting on nucleic acids as therapeutic targets , 2012 .

[23]  R. Klose,et al.  The oncometabolite 2‐hydroxyglutarate inhibits histone lysine demethylases , 2011, EMBO reports.

[24]  J. Hale,et al.  Prolyl hydroxylase domain-containing protein inhibitors as stabilizers of hypoxia-inducible factor: small molecule-based therapeutics for anemia , 2010, Expert opinion on therapeutic patents.

[25]  Cheng Luo,et al.  Development of cell-active N6-methyladenosine RNA demethylase FTO inhibitor. , 2012, Journal of the American Chemical Society.

[26]  Z. Otwinowski,et al.  [20] Processing of X-ray diffraction data collected in oscillation mode. , 1997, Methods in enzymology.

[27]  Roger D. Cox,et al.  Overexpression of Fto leads to increased food intake and results in obesity , 2010, Nature Genetics.

[28]  T. Pan,et al.  The AlkB domain of mammalian ABH8 catalyzes hydroxylation of 5-methoxycarbonylmethyluridine at the wobble position of tRNA. , 2010, Angewandte Chemie.

[29]  F. Kirpekar,et al.  ALKBH8-mediated formation of a novel diastereomeric pair of wobble nucleosides in mammalian tRNA. , 2011, Nature communications.

[30]  A. Mai,et al.  A photoreactive small-molecule probe for 2-oxoglutarate oxygenases. , 2011, Chemistry & biology.

[31]  U. Oppermann,et al.  Inhibitor scaffolds for 2-oxoglutarate-dependent histone lysine demethylases. , 2008, Journal of medicinal chemistry.